1 year return (CAGR)
-79.92%
Atossa Genetics Inc Exchange (NASDAQ, USD)
ATOS
2.48
-0.03 (-1.20%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-39.42%
5 year return (CAGR)
-46.44%
10 year return (CAGR)
-40.34%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
24.75M
Price/Sales
-
Ent value
4.11M
Price/Book
0.92
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-29.78%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.53 |
| Daily high | 2.56 |
| Daily low | 2.45 |
| Daily Volume | 35K |
| All-time high | 33399.00 |
| 1y analyst estimate | 18.67 |
| Beta | 1.25 |
| EPS (TTM) | -4.23 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| ATOS | S&P500 | |
| Current price drop from All-time high | -99.99% | -2.19% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 24 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -93.73% | -10.68% |
| Avg time to new high | 205 days | 12 days |
| Max time to new high | 3393 days | 1805 days |
News
